CinCor Pharma Inc
NASDAQ:CINC
Earnings Announcements
CinCor Reports Q1 Net Loss Of $0.50 Per Share
Published: 05/10/2022 12:15 GMT
CinCor Pharma Inc (CINC) - Cincor Reports First Quarter Financial Results and Provides Corporate Update.
Qtrly Net Loss per Common Share, Basic and Diluted $0.50.
Cash, Cash Equivalents and Marketable Securities Were $314.2 Million As of March 31, 2022.
Qtrly Net Loss per Common Share, Basic and Diluted $0.50.
Cash, Cash Equivalents and Marketable Securities Were $314.2 Million As of March 31, 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.50
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58
More details on our Analysts Page.